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Targeting Hif1a rescues cone degeneration
and prevents subretinal neovascularization
in a model of chronic hypoxia
Maya Barben1,2, Christian Schori1,3, Marijana Samardzija1*† and Christian Grimm1,2,3†
Abstract
Background: Degeneration of cone photoreceptors leads to loss of vision in patients suffering from age-related
macular degeneration (AMD) and other cone dystrophies. Evidence, such as choroidal ischemia and decreased
choroidal blood flow, implicates reduced tissue oxygenation in AMD pathology and suggests a role of the cellular
response to hypoxia in disease onset and progression. Such a chronic hypoxic situation may promote several
cellular responses including stabilization of hypoxia-inducible factors (HIFs).
Methods: To investigate the consequence of a chronic activation of the molecular response to hypoxia in cones, von
Hippel Lindau protein (VHL) was specifically ablated in cones of the all-cone R91W;Nrl-/- mouse. Retinal function and
morphology was evaluated by ERG and light microscopy, while differential gene expression was tested by real-time
PCR. Retinal vasculature was analyzed by immunostainings and fluorescein angiography. Two-way ANOVA with Šídák’s
multiple comparison test was performed for statistical analysis.
Results: Cone-specific ablation of Vhl resulted in stabilization and activation of hypoxia-inducible factor 1A (HIF1A) which
led to increased expression of genes associated with hypoxia and retinal stress. Our data demonstrate severe cone
degeneration and pathologic vessel growth, features that are central to AMD pathology. Subretinal neovascularization was
accompanied by vascular leakage and infiltration of microglia cells. Interestingly, we observed increased expression of tissue
inhibitor of metalloproteinase 3 (Timp3) during the aging process, a gene associated with AMD and Bruch’s membrane
integrity. Additional deletion of Hif1a protected cone cells, prevented pathological vessel growth and preserved vision.
Conclusions: Our data provide evidence for a HIF1A-mediated mechanism leading to pathological vessel growth and
cone degeneration in response to a chronic hypoxia-like situation. Consequently, our results identify HIF1A as a potential
therapeutic target to rescue hypoxia-related vision loss in patients.
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Background
Age-related macular degeneration (AMD) is the leading
cause of visual impairment in the elderly population in in-
dustrialized nations [1–3]. Due to the degeneration of
photoreceptors in the cone-rich macula and/or the in-
growth of blood vessels, patients suffering from AMD lose
central, high acuity vision [4–6]. While there is no therapy
available for geographic atrophy (dry AMD), the
neovascular (wet) form of AMD is treated by vascular
endothelial growth factor (VEGF)-targeting therapies to
slow disease progression [7–9]. Choroidal neovasculariza-
tion (CNV) defines the classic form of neovascular AMD
and is characterized by the ingrowth of blood vessels from
the choroid to the subretinal space [6, 10]. Retinal angio-
matous proliferation (RAP) has been described as an add-
itional, distinct form of neovascular AMD [11]. In RAP,
also known as deep retinal vascular anomalous complexes,
vessels originate not from the choroid but from the deep
retinal plexus in the inner retina and extend into the
photoreceptor layer and the subretinal space [12, 13].
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AMD is a multifactorial disease. Besides genetic and
environmental risk factors [5, 14, 15], tissue hypoxia
and changes in retinal blood flow have been impli-
cated in its etiology [16–20]. Oxygen supply to photo-
receptors in the eyes of elderly people may be
impaired due to an age-dependent reduction of chor-
oidal blood flow [21, 22] and accumulation of drusen
[23]. Choroidal ischemia in dry AMD [24, 25] and de-
creased choroidal blood volume in AMD [26] further
support the hypothesis that hypoxia might be impli-
cated in disease development and progression. The
retina is considered as one of the most metabolically
active tissues and is therefore highly vulnerable to
changes in oxygen tension [17, 27]. In conditions of
reduced oxygen supply (hypoxia), molecular responses
are activated with hypoxia-inducible factor 1 (HIF1)
playing a key regulatory role for adapting the cell/tis-
sue to the new condition. Heterodimeric HIF1 pro-
teins are composed of an oxygen-labile α-subunit and
a constitutively expressed β-subunit [28]. Under nor-
moxic conditions, HIF1A is hydroxylated by prolyl
hydroxylase domain (PHD) proteins. This promotes
the interaction with the von Hippel-Lindau (VHL)
ubiquitin E3 ligase complex leading to ubiquitination
and rapid degradation of hydroxylated HIF1A by pro-
teasomes. Under hypoxic conditions, hydroxylation of
HIF1A is reduced. Hence, HIF1A accumulates, enters
the nucleus and drives transcription of a multitude of
target genes [29–31].
In this study, we investigated the consequences of a
chronic hypoxia-like response triggered in cone photore-
ceptors to elucidate the mechanisms of cell death in cone
degenerative diseases such as AMD. To this end, we used
R91W;Nrl-/- double-mutant mice which express only cone
photoreceptors in a well-layered, functional retina [32].
To induce the hypoxia-like response, we ablated the VHL
protein specifically from cones using the Cre-loxP system.
We analyzed the effects of the cone-specific activation of
the hypoxic response and validated the contribution of
HIF1A to the resulting retinal pathology.
Methods
Mice
All experimental procedures were performed according to
‘The Association for Research in Vision and Ophthalmol-
ogy’ statement on animal use in ophthalmic and vision re-
search and the regulation of the veterinary authorities
of Kanton Zurich, Switzerland. R91W;Nrl-/- mice were
generated by crossing Rpe65R91W (R91W) [33] to Nrl-/-
mice [34], and were described recently [32].
BPCre;R91W;Nrl-/-;Vhlf/f (=coneΔVhl) mice were generated
by breeding R91W;Nrl-/- mice to Vhlf/f mice [35] and mice
expressing the Cre recombinase under the transcriptional
control of the blue cone opsin (BP) promoter [36]. To
generate BPCre;R91W;Nrl-/-;Vhlf/f;Hif1af/f (=coneΔVhlHif1a)
mice, BPCre;R91W;Nrl-/-;Vhlf/f were bred to Hif1af/f mice
[37]. R91W;Nrl-/-;Vhlf/f and R91W;Nrl-/-;Vhlf/f;Hif1af/f lit-
termates without Cre recombinase served as respective
control mice (=ctrl). Genotyping was performed by PCR
using DNA isolated from ear clips and primer pairs as de-
scribed previously [38, 39]. Presence of BPCre was tested
using the following primer pair: forward (5’-GGA-
CATGTTCAGGGATCGCCAGGCG-3’) and reverse (5’-
GCATAACCAGTGAAACAGCATTGCTG-3’). The amp-
lification reaction resulted in a 268 bp fragment in the
presence of the transgene. To test for deletion of floxed
sequences, genomic DNA was isolated from retinal tissues
and tested by PCR using appropriate primer pairs as de-
scribed [38, 39]. 129S6 (Taconic, Ejby, Denmark) mice
were used as wild-type controls. To test expression of the
Cre recombinase BPCre;R91W;Nrl-/- mice were bred to a
ZsGreen reporter line (Ai6 mice, Gt(ROSA)26Sortm6(CAG-
ZsGreen1)Hze, [40]). Mice of both sexes were used for experi-
ments and were housed at the animal facility of the Uni-
versity Zurich under a 14 h : 10 h light/dark cycle with
lights on at 6 am and lights off at 8 pm. Food and water
were provided ad libitum.
Morphology/quantification
To evaluate retinal morphology, eyes were enucleated
and fixed in 2.5% glutaraldehyde in cacodylate buffer
(pH 7.2, 0.1 M), according to the previously described
procedure [41]. By cutting through the optic nerve head,
nasal and temporal halves of the eyecups were separated
and embedded in epon plastic. Semi-thin cross sections
(0.5 μm) were counterstained with toluidine blue and ana-
lyzed by light microscopy (Axioplan; Zeiss, Jena, Germany).
Thickness of the outer nuclear layer was measured at indi-
cated distances from the optic nerve head using the Adobe
Photoshop CS6 ruler tool (Adobe Systems, Inc., San Jose,
CA, USA) on reconstructed retinal panorama images.
Immunofluorescence
After euthanasia, eyes were marked nasally, enucleated
and fixed in 4% paraformaldehyde (PFA) in phosphate
buffer for 1 h at 4°C. Cornea and lens were removed and
the dissected eyecups postfixed for 2 h in 4% PFA. After
immersion in 30% sucrose (in PBS 0.1 M) the eyecups
were embedded in tissue freezing medium (O.C.T., Leica
Biosystems Nussloch GmbH, Nussloch, Germany), fro-
zen in a 2-methylbutane bath cooled by liquid nitrogen
and stored at -80°C. Cryosections (12 μm) were blocked
(3% normal goat serum (Sigma-Aldrich, St. Louis, MO,
USA), 0.3% Triton X-100 (Sigma) in PBS) and incubated
with the following primary antibodies overnight at 4°C:
Isolectin GS-IB4-Alexa594 from Griffonia simplicifolia
(1:300, I21413; Thermo Fisher Scientific, Waltham, MA,
USA), rabbit anti-allograft inflammatory factor 1 (alias
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IBA1, 1:1000, 019-19741; Wako, Neuss, Germany),
rabbit anti-albumin (ALB, 1:500, RARaAlb; Nordic Im-
munology, Tilburg, Netherlands). Sections were washed
with PBS, incubated with secondary antibodies (Cy3-la-
beled, Jackson ImmunoResearch Laboratories, West-
grove, PA, USA) for 1 h at room temperature (RT),
counterstained with DAPI (4',6-Diamidine-2'-phenylin-
dole dihydrochloride, Roche, Basel, Switzerland) and an-
alyzed by fluorescence microscopy (Axioplan; Zeiss).
Analysis of retinal vasculature in whole mounted retinas
Eyes were isolated and incubated for 5 to 10 minutes in
2% PFA in PBS as described recently [42]. After removal
of cornea and lens, the retina was dissected and flat-
mounted in PBS. After postfixation in 4% PFA for 1 h at
RT, flat-mounts were blocked (3% normal goat serum,
0.3% Triton X-100 in PBS, 1 h) and incubated with iso-
lectin GS-IB4-Alexa594 (1:300, Thermo Fisher Scientific)
at 4°C overnight. Retinas were washed in PBS, mounted
on glass slides and analyzed by fluorescence microscopy
(Axioplan/ApoTome; Zeiss). Blood vessels were recon-
structed in three dimensions using Imaris software (Ver-
sions 7.7.2/8.3.0, Bitplane AG, Zurich, Switzerland). For
better recognition and distinction of the vascular plexi,
the z-value of the z-stacks was increased five times.
RNA isolation and semi-quantitative real-time PCR
Retinas were isolated through a slit in the cornea, frozen
in liquid nitrogen and stored at -80°C. RNA was ex-
tracted using an RNA isolation kit (RNeasy; Qiagen, Hil-
den, Germany) including a DNAse treatment. 1 μg of
RNA, oligo (dT) and M-MLV reverse transcriptase (Pro-
mega, Fitchburg, WI, USA) were used to prepare cDNA.
To analyze gene expression by real-time PCR, 10 ng of
cDNA template was amplified using a PCR polymerase
ready mix (LightCycler 480 SYBR Green I Master, Roche
Diagnostics, Rotkreuz, Switzerland), specific primer pairs
(Table 1) and a thermocycler (LightCycler 480, Roche
Diagnostics). Expression levels were normalized to β-
actin (Actb) and relative expression was calculated using
the comparative threshold cycle method (ΔΔCT) of the
LightCycler480 software (Roche Diagnostics). At least 3
mice per strain and time point were used.
Protein isolation and Western blotting
Proteins were isolated by homogenizing the retinas in
ice-cold Tris-HCl (100 mM, pH 7.5) using ultrasound at
4°C. Protein concentrations were determined spectro-
photometrically by using Bradford reagent (Bio-Rad,
Hercules, CA, USA). SDS-PAGE and Western blotting
were performed as described [41] and proteins detected
by rabbit anti-HIF1A (1:2000, NB100-479, Novus Biolog-
icals, Littleton, CO, USA) and mouse anti-β-actin
(1:10’000, A5441, Sigma-Aldrich) antibodies. HRP-
conjugated secondary antibodies were applied for 1 h at
RT and signals were visualized using Western lightning
chemiluminescence reagent (PerkinElmer, Waltham,
MA, USA) and X-ray films.
Electroretinography (ERG)
Mice were dark-adapted overnight and pupils were dilated
under dim red light with 1% cyclogyl (Alcon Switzerland
SA, Rotkreuz, Switzerland) and 5% neosynephrin-POS
(Ursapharm Schweiz GmbH, Roggwil, Switzerland) 30 mi-
nutes prior to recording. Mice were anesthetized with a
subcutaneous injection of ketamine (85 mg/kg, Pfizer PFE
Switzerland GmbH, Zurich, Switzerland) and xylazine
(Rompun 2%, 4mg/kg, Bayer, Leverkusen, Germany). To
keep the cornea moist, a drop of mydriaticum dispersa
(Omnivision AG, Neuhausen, Switzerland) was applied to
each eye. Low background illumination for 5 min was
used for light adaptation. Electroretinograms were re-
corded simultaneously from both eyes with an LKC UTAS
Bigshot unit (LKC Technologies, Inc. Gaithersburg, MD,
USA) as described [32]. Flashes of 8 different light inten-
sities ranging from -10 to 25 dB (0.25–790.5694 cd*s/m2)
were applied under photopic conditions. 10 responses
were averaged per light intensity. Traces from n≥4 mice
were averaged for each light intensity.
Fundus imaging and fluorescein angiography
Fundus photographs were taken with a Micron IV sys-
tem (Phoenix Research Labs, Pleasanton, CA, USA). The
pupils were dilated and the mice were anesthetized as
described above. Methocel 2% (Omnivision) was applied
to lubricate the eyes. Fluorescein images were captured
1-5 minutes after intraperitoneal injection of 20 μL of
2% fluorescein solution (Akorn, Lake Forest, IL, USA).
Experimental design and statistical analysis
Two-way ANOVA with Šídák’s multiple comparison test
was performed using GraphPad Prism (version 7.02,
GraphPad Software, San Diego, CA, USA) for statistical
analysis of gene expression levels and ERG traces. All
data are shown as means ± SD.
Results
Cone-specific inactivation of Vhl increased HIF1A target
gene expression and induced progressive cone
degeneration
Photoreceptors in the all-cone R91W;Nrl-/- mouse are
predominantly blue-light sensitive S-cones [32, 34].
Therefore, we used BP-Cre transgenic mice, which ex-
press functional Cre recombinase under the transcrip-
tional control of the blue cone opsin promoter (BP, [36])
to delete floxed sequences from cones in the all-cone
mice. BPCre;R91W;Nrl-/-;ZsGreen reporter mice verified
that Cre expression was uniform over the entire retina
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Fig. 1 Knockdown of Vhl in cones of the all-cone mouse (coneΔVhl). a Expression of Cre recombinase in BPCre;R91W;Nrl-/-;ZsGreen mice. Green fluor-
escence (ZsGreen) indicates Cre activity. RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, IPL: inner plexiform
layer, GCL: ganglion cell layer. Scale bar 50 μm. b PCR of genomic DNA from retinas of 4-week-old ctrl and coneΔVhl mice. Floxed Vhl (fl) is de-
tected at 460 bp and Cre-mediated excision (ex) results in a 260 bp fragment. c Western blot analysis of HIF1A in 4, 6, 8 and 12-week-old coneΔVhl
and ctrl (littermates without Cre recombinase) mice. ACTB served as loading control. d Relative expression of hypoxic target genes in retinas of ctrl
(black) and coneΔVhl (orange) mice. Expression levels were normalized to beta-actin (Actb) and calculated relatively to 4-week-old ctrl mice, which
were set to 1. Shown are means ± SD. Two-way ANOVA with Šídák’s multiple comparison test was used for statistical analysis (Adm: ****p<0.0001,
*p=0.0306; Egln1: ****p<0.0001; Glut1: ****p<0.0001; Bnip3: ****p<0.0001, **p=0.0043; n≥3 per time point). Adm: Adrenomedullin, Egln1: egl-9 fam-
ily hypoxia-inducible factor 1, Glut1: Glucose transporter 1, Bnip3: BCL2/adenovirus E1B interacting protein 3. Cre-negative littermates were used as
ctrl mice in all experiments unless otherwise indicated
Table 1 Primers used for real-time PCR
Gene Forward (5’-3’) Reverse (5’-3’) Product (bp)
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153
Adm TCCTGGTTTCTCGGCTTCTC ATTCTGTGGCGATGCTCTGA 133
Bnip3 CCTGTCGCAGTTGGGTTC GAAGTGCAGTTCTACCCAGGAG 93
Casp1 GGCAGGAATTCTGGAGCTTCAA GTCAGTCCTGGAAATGTGCC 138
Fgf2 TGTGTCTATCAAGGGAGTGTGTGC ACCAACTGGAGTATTTCCGTGACCG 158
Gfap CCACCAAACTGGCTGATGTCTAC TTCTCTCCAAATCCACACGAGC 240
Glut1 CAGTGTATCCTGTTGCCCTTCTG GCCGACCCTCTTCTTTCATCTC 151
Pdgfb GCTGCTGCAATAACCGCAAT GTGGTCCTCCAAGGTCACTG 131
Pdgfrb CTTGCCCTTCAAAGTGGTGG CCAGGTGGAGTCGTAAGGC 199
Egln1 GCAGCATGGACGACCTGAT CAACGTGACGGACATAGCCT 123
Sema3f CGTCGCGCACAGGATTA GGAAAATGGCTGCATCGGTA 166
Timp3 GCCTCAAGCTAGAAGTCAACAAA TGTACATCTTGCCTTCATACACG 69
Vegf ACTTGTGTTGGGAGGAGGATGTC AATGGGTTTGTCGTGTTTCTGG 171
vWF CCCTGGACAACTTGACAGCAG ACAAGCAGGCAGATCTCATACC 192
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and restricted almost exclusively to the majority of cones
in the ONL (Fig. 1a). Green fluorescence of the activated
reporter protein was only occasionally detected in few
cells of the inner retina. We validated Vhl excision in
the BPCre;R91W;Nrl-/-;Vhlf/f (=coneΔVhl) mouse line
by analyzing genomic DNA isolated from retinal tis-
sues of 4-week-old coneΔVhl mice. The detection of a
PCR product corresponding to the excised fragment
suggested a successful Cre-mediated deletion of Vhl
in retinas of coneΔVhl but not of ctrl mice
(=R91W;Nrl-/-;Vhlf/f, Fig. 1b). Genomic deletion of Vhl
led to the accumulation of HIF1A protein (Fig. 1c)
and to increased transcript levels of known hypoxic
target genes such as adrenomedullin (Adm), egl-9
family hypoxia-inducible factor 1 (Egln1, also known
as Phd2), glucose transporter 1 (Glut1) and BCL2/
adenovirus E1B 19-kDa interacting protein 3 (Bnip3)
in normoxic coneΔVhl mice (Fig. 1d). This suggested
that cells, presumably cones, activated a hypoxia-like
response in retinas of coneΔVhl mice.
We observed an age-dependent decline in HIF1A
protein levels and hypoxia target gene expression in
coneΔVhl mice (Fig. 1c, d). This prompted us to
analyze retinal function and morphology. B-wave am-
plitudes and photopic ERGs were not significantly dif-
ferent between coneΔVhl mice and ctrl mice at 6
weeks of age (Fig. 2a). However, the amplitudes were
strongly reduced in 12-week-old coneΔVhl mice as
compared to age-matched ctrl mice (Fig. 2b). This in-
dicated an age-dependent loss of function potentially
due to retinal degeneration. Indeed, we observed se-
vere, progressive thinning of the outer nuclear layer
(ONL) in coneΔVhl mice with most cones lost at 26
weeks of age (Fig. 3a, b). Additionally, partial loss of
Fig. 2 Reduced retinal function in aged coneΔVhl mice. a Averaged traces of single-flash photopic ERGs and b-wave amplitudes showed no significant
differences in coneΔVhl mice (orange) compared to ctrl mice (black) at 6 weeks of age. b At 12 weeks of age, photopic b-wave amplitudes were strongly
reduced in coneΔVhl mice (orange) as compared to ctrl mice (black). b-wave amplitudes are shown as means ± SD. Two-way ANOVA with Šídák’s
multiple comparison test was used for statistical analysis (6we ctrl and coneΔVhl n=5, 12we ctrl n=6 and coneΔVhl n=4, *p=0.0115, ****p<0.0001)
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Fig. 3 (See legend on next page.)
Barben et al. Molecular Neurodegeneration  (2018) 13:12 Page 6 of 14
the retinal pigment epithelium (RPE) and strong per-
turbations in the inner nuclear layer (INL) were de-
tected in older coneΔVhl mice (Fig. 3a, 12we coneΔVhl).
In contrast, the ctrl mice showed only a slow age-
related ONL thinning, as reported for the parental
R91W;Nrl-/- mouse line before [32].
To gain insight into cellular mechanisms leading to
cone degeneration, we analyzed expression of specific
genes during aging in coneΔVhl and ctrl mice (Fig. 3c).
Caspase 1 (Casp1), a gene involved in retinal degener-
ation, was upregulated in coneΔVhl mice at 8 weeks
and peaked at 12 weeks of age. Expression of the
stress signaling gene glial fibrillary acidic protein
(Gfap) was upregulated in coneΔVhl mice already at 4
weeks and remained elevated throughout the observa-
tion period. Interestingly, we observed increased ex-
pression of tissue inhibitor of metalloproteinase 3
(Timp3) during the aging process, a gene associated
with age-related macular degeneration [43, 44]. Simi-
larly, expression of vascular endothelial growth factor
(Vegf ), a hypoxic response gene that is involved in
neovascularization in wet AMD, was strongly in-
creased in coneΔVhl mice at 4 and 6 weeks of age.
Subretinal neovascularization and vascular leakage in
coneΔVhl mice
Increased transcription of Timp3 is potentially associated
with a higher risk to develop neovascular AMD [43] and
hypoxia-regulated genes such as Vegf contribute to ret-
inal and choroidal neovascularization (reviewed in [45]).
Therefore, we analyzed the vascular network of coneΔVhl
mice. All three vascular plexi were detected at 4 weeks
of age (Fig. 4a, b, c). However, we observed vessels ex-
tending from the deep plexus into the normally avascu-
lar ONL in central retinas of coneΔVhl mice (Fig. 4a,
arrowheads). Vessels reached the RPE but did not cross
Bruch’s membrane (Fig. 4d, e), as we never observed
retinal-choroidal anastomoses. This suggests that abnor-
mal vessels originated from the retinal vasculature and
not from the choroid. Interestingly, abnormal vessel
growth was characteristic for the central but not for the
peripheral retina (Fig. 4b). To evaluate the integrity of
retinal vessels we performed fluorescein angiography.
Signs of leakage were observed in coneΔVhl mice (Fig. 4f,
g). To confirm these findings we stained retinal cross-
sections for albumin (ALB), a marker for blood extrava-
sation. Detailed analysis revealed strong ALB immunore-
activity in the ONL, RPE and inner plexiform layer (IPL)
in coneΔVhl mice, as opposed to the signal detected in
ctrl mice that was confined to retinal vessels. The chor-
oid with its extensive vasculature was also strongly posi-
tive for ALB in both types of mice (Fig. 4h, i). Microglia/
macrophages detected by IBA1 staining were found
within the photoreceptor and subretinal layer in coneΔVhl
but not ctrl mice (Fig. 4j, k).
Early vascular defects in coneΔVhl mice
S-opsin expression starts shortly before birth in mice
[46, 47] and we observed Cre-activity in
BPCre;R91W;Nrl-/-;ZsGreen reporter mice as early as at
postnatal day (PND) 1 (data not shown). The primary
plexus in mice develops along a central-to-peripheral
gradient and reaches the periphery around PND8-10
[48]. Vessels sprout from the primary plexus into the
retina and turn laterally when they reach the outer and
inner boundaries of the INL to first form the deep
plexus and subsequently the intermediate plexus [48].
To determine the onset of neovascularization in coneΔVhl
mice we stained retinal flat mounts with isolectin at
PND7 and PND11. Using 3D-reconstruction of blood
vessels, no difference in early vessel formation was de-
tected between coneΔVhl and ctrl mice at PND7 (Fig. 5a).
However, at PND11, before formation of the intermedi-
ate plexus, vessels growing from the deep plexus into
the ONL were observed in coneΔVhl mice (Fig. 5b).
Formation of the deep plexus is preceded by Vegf ex-
pression in the INL [49]. We analyzed gene expression
levels in coneΔVhl, ctrl and 129S6 (wt, rod-dominant ret-
ina) mice to test for different regulation of genes in-
volved in angiogenesis and vessel guidance during and
after the process of vessel formation (PND7, 14 and 28,
Fig. 5c). Vegf mRNA was not elevated at PND7, slightly
increased by 1.3-fold at PND14 and significantly in-
creased at PND28 (2-fold) in coneΔVhl mice compared to
controls. Fibroblast growth factor 2 (Fgf2), a potent an-
giogenic factor that has been shown to be involved in
retinal stress [50–52], was upregulated at PND28, at a
time when developmental vascularization is completed.
(See figure on previous page.)
Fig. 3 Progressive cone degeneration in coneΔVhl mice. a Inactivation of Vhl in cones led to progressive retinal degeneration (upper panels) as
compared to ctrl mice (lower panels). ConeΔVhl mice displayed disturbed layering with reorganization of the INL (asterisk, 12we coneΔVhl), severe
loss of the ONL and partial loss of the RPE (arrowhead, 12we coneΔVhl, inset) at 12 and 26 weeks of age. Abbreviations as in Fig. 1. Scale bar 50
μm. b Line chart of ONL thickness in coneΔVhl mice (orange) as compared to ctrl mice (black) at 4 and 12 weeks of age. n≥3. c Relative expression
levels of genes involved in stress signaling and degeneration. Expression levels were normalized to Actb and calculated relatively to 4-week-old
ctrl mice, which were set to 1. Shown are means ± SD. Two-way ANOVA with Šídák’s multiple comparison test was used for statistical analysis
(Casp1: **p=0.0026, ****p<0.0001, *p=0.0244, Gfap: ****p<0.0001, **p=0.0035, ***p=0.0004, ****p<0.0001, Timp3: *p=0.0235, **p=0.0036, **p=0.0035,
Vegf: ****p<0.0001, n≥3 per time point). Casp1: caspase 1, Gfap: glial fibrillary acidic protein, Timp3: tissue inhibitor of metalloproteinase 3, Vegf:
vascular endothelial growth factor
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Recently, protective effects of semaphorin 3F (Sema3f )
against subretinal neovascularization have been demon-
strated [53]. We thus analyzed Sema3f gene expression
levels to test for potential differential expression of this
anti-angiogenic factor in coneΔVhl mice. However,
expression of Sema3f in all-cone mice did not differ be-
tween ctrl and coneΔVhl mice (Fig. 5c). On the other
hand, a pro-angiogenic factor, platelet derived growth
factor, B polypeptide (Pdgfb), was upregulated in con-
eΔVhl compared to ctrl mice at PND28. Pdgfb expression
Fig. 4 Subretinal neovascularization in coneΔVhl mice. a-c Immunostaining of cross-sections of the central (a) and peripheral (b) retina of
4-week-old coneΔVhl and age-matched ctrl mice (c, central retina) with isolectin. Arrowheads indicate vessels extending from the deep
plexus into the ONL in central retinas of coneΔVhl mice. DP: deep plexus, IP: intermediate plexus, PP: primary plexus. Scale bar 50 μm.
d, e Light microscopy of 4-week-old coneΔVhl and ctrl mice. Neovessels (arrowheads) reached the RPE, but did not cross Bruch’s membrane. Scale bar
20 μm. f, g Fundus imaging and fluorescein angiography of coneΔVhl mice and ctrl mice at 4 weeks of age. Signs of leakage (arrowhead) were detected
in coneΔVhl mice. h-k Retinal cross-sections of ctrl h, j and coneΔVhl mice (i, k) were stained with antibodies against ALB (h, i) and IBA1 (j, k) at 4 weeks
of age. Microglia/macrophages were found within the photoreceptor layer and RPE in coneΔVhl mice (arrowheads). Scale bar 50 μm. Abbreviations as
in Fig. 1
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by endothelial cells is essential for pericyte recruitment
and is increased under hypoxia [54–57]. Surprisingly, ex-
pression levels of von Willebrand factor (vWf ), a marker
for endothelial cells, as well as of Pdgfb receptor (Pdgfrb),
which is expressed by pericytes/mural cells [58–61],
were not increased in coneΔVhl mice as compared to
controls. The reason for this unexpected pattern of ex-
pression is not clear and requires further investigation.
HIF1 is responsible for pathological vessel growth and
progressive cone degeneration in coneΔVhl mice
We hypothesized that stabilized HIF1A, and not other
Vhl targets, might promote retinal degeneration and
neovascularization in coneΔVhl mice. Therefore, we
additionally deleted Hif1a in cone photoreceptors
(BPCre;R91W;Nrl-/-;Vhlf/f;Hif1af/f=coneΔVhlHif1a). After
we confirmed the presence of deletion alleles for both
Hif1a and Vhl in genomic DNA of coneΔVhlHif1a retinas
(not shown) we determined retinal function. At 12
weeks of age, photopic ERG traces and b-wave ampli-
tudes were similar in coneΔVhlHif1a and ctrl (R91W;Nrl-/-;
Vhlf/f;Hif1af/f ) mice (Fig. 6a, b) indicating no functional
loss upon combined Hif1a and Vhl inactivation. Simi-
larly, retinal morphology (Fig. 6c) and ONL thickness
(Fig. 6d) of coneΔVhlHif1a mice was comparable to ctrl
mice, whereas the thickness of the ONL in coneΔVhl mice
was prominently reduced (same data as in Fig. 3b) at 12
weeks of age.
Combined deletion of Hif1a and Vhl also prevented
pathological neovascularization into the ONL but had
no effect on the developmental formation of the three
vascular plexi (Fig. 6e). No induction of the expression
Fig. 5 Pathological vessel growth starts around PND11 in coneΔVhl mice. a, b 3D-reconstruction of blood vessels stained with isolectin on
retinal flat mounts of ctrl (left) and coneΔVhl (right) mice at PND7 (a) and PND 11 (b). At PND11, vessels extended from the deep plexus
towards the ONL. The intermediate plexus has not yet been formed in both ctrl and coneΔVhl mice. For better recognition and distinction
the z-value of the z-stacks was increased five times. DP: deep plexus, PP: primary plexus. Scale bar 50 μm. c Relative expression levels of
angiogenic genes in retinas of coneΔVhl (orange), ctrl (black) and wt (green) mice at indicated time points. Expression levels were
normalized to Actb and compared to ctrl mice at PND7, which were set to 1. Shown are means ± SD. Two-way ANOVA with Šídák’s
multiple comparison test was used for statistical analysis comparing ctrl with coneΔVhl mice (Vegf: ****p<0.0001, Fgf2: ****p<0.0001, Pdgfb:
***p=0.0009, n=3 per time point). Vegf: vascular endothelial growth factor, Fgf2: fibroblast growth factor 2, Sema3f: semaphorin 3F, Pdgfb:
platelet derived growth factor, B polypeptide, vWf: von Willebrand factor, Pdgfrb: platelet derived growth factor receptor, beta polypeptide
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Fig. 6 (See legend on next page.)
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of hypoxic target genes such as Adm, Egln1, Vegf and
Timp3 was detected in coneΔVhlHif1a mice, confirming
that HIF1 was the responsible HIF isoform for regulating
their expression in cones (Fig. 6f ). Altogether, these data
demonstrate that combined deletion of Hif1a and Vhl
(coneΔVhlHif1a mice) rescues the retinal phenotype ob-
served in coneΔVhl mice and identify HIF1 as the causa-
tive factor for retinal degeneration and pathological
vessel growth in coneΔVhl mice.
Discussion
Previously, it has been demonstrated that the knockdown
of Vhl in rod cells causes HIF1A stabilization under nor-
moxic conditions [39]. Here, we particularly investigated
the effects of a chronic hypoxia-like response in cone pho-
toreceptors. We show that ablation of Vhl in cones re-
sulted in a chronic hypoxia-like situation with
accumulation of HIF1A and induction of HIF1A target
genes. This led to pathological vessel growth into the
photoreceptor layer, reduced retinal function and severe,
progressive cone degeneration. These consequences re-
semble some of the features of AMD pathology, particu-
larly of a subset of neovascular AMD known as RAP. In
human patients, HIF1A and HIF2A were detected in mac-
rophages and endothelial cells of neovascular membranes
associated with AMD [62]. Additionally, the correlation of
drusen density and decreased choroidal blood flow [26] as
well as choroidal ischemia in AMD patients [23–25] sug-
gest reduced oxygen transport from the choroid to the
inner retina [63]. Therefore, tissue hypoxia and HIFs
might play an important role in disease development and/
or progression.
Expression of numerous genes involved in metabolism,
stress, cell survival and angiogenesis was increased in
coneΔVhl mice (Fig. 1d, 3c, 5c), as was Timp3 (Fig. 3c).
TIMP3 is an important regulator of extracellular matrix
(ECM) remodeling through inhibition of matrix metallo-
proteases and has been suggested to be a senescence-
related protein [64] that is potentially regulated by HIF2
in rods [38]. Importantly, TIMP3 inhibits angiogenesis
by interacting with VEGF [65] and is relevant for Bruch’s
membrane integrity [64, 66]. Furthermore, mutations in
Timp3 have been associated with Sorsby’s fundus dys-
trophy, an autosomal dominant maculopathy with sub-
macular choroidal neovascularization [67, 68]. We can
only speculate about the reasons for elevated Timp3 dur-
ing the aging process in coneΔVhl mice but it seems
plausible that retinas of coneΔVhl mice require extensive
ECM remodeling due to progressive cone degeneration
(Fig. 3).
We detected early and prominent vascular defects with
abnormal vessel growth into the ONL, subretinal space
and RPE layer in coneΔVhl mice. Increased VEGF levels
in transgenic mice expressing Vegf under the transcrip-
tional control of the rhodopsin promoter (rho/VEGF
mice) were shown to cause subretinal neovascularization
[69–71]. In our model, Vegf was not upregulated at
PND14, at a time when vessels had already started grow-
ing into the ONL (Fig. 5). However, transient Vegf ex-
pression in the INL regulates the formation of the deep
plexus during development [49], i.e. already minor
changes in the local Vegf concentration gradient, which
are not detectable by RT-PCR, may misguide retinal ves-
sels in coneΔVhl mice. To date, it remains unclear which
pro-angiogenic factor(s) are responsible for the observed
neovascularization. Nonetheless, our findings demon-
strate that this is a Hif1a-mediated mechanism, as add-
itional deletion of Hif1a fully rescued the vascular
defects (Fig. 6).
Interestingly, cone-specific deletion of Hif1a did not
affect formation of the three vascular plexi (Fig. 6e),
while it has been shown that knockdown of Hif1a in
most cells of the retinal periphery prevented formation
of the intermediate plexus [42]. Thus, our results suggest
that Hif1a expression in cones, as opposed to other cells
presumably in the INL, is not essential for the develop-
ment of the intermediate plexus.
Our data do not define whether cone degeneration in
coneΔVhl mice is due to the effects of the chronic intrin-
sic activation of the hypoxic response or to early devel-
opment of vascular defects. Another mouse model
shows, however, that a chronic hypoxia-like response in
rods leads to slow photoreceptor degeneration in the ab-
sence of reported vascular defects (rodΔVhl mice [39]).
(See figure on previous page.)
Fig. 6 Combined deletion of Hif1a and Vhl (coneΔVhlHif1a) rescues the defects in retinal function, morphology and vasculature observed in coneΔVhl
mice. a, b Average single-flash photopic ERGs and b-wave amplitudes showed no significant differences in coneΔVhlHif1a mice (green) compared to ctrl
mice (R91W;Nrl-/-;Vhlf/f; Hif1af/f, black) at 12 weeks of age. n=4 per group. b-wave amplitudes are shown as means ± SD. c, d Light microscopy analysis
and measurement of the ONL thickness in coneΔVhlHif1a (green), ctrl mice (R91W;Nrl-/-;Vhlf/f; Hif1af/f, black) and coneΔVhl mice (orange, as shown in Fig. 3b)
at indicated time points. Abbreviations as in Fig. 1. Scale bar 50 μm. e 3D-reconstruction of blood vessels stained with isolectin on retinal flat mounts
of ctrl (left), coneΔVhl (middle) and coneΔVhlHif1a mice (right). Inactivation of Hif1a (coneΔVhlHif1a) rescued the pathological neovascularization. Analysis at 4
weeks of age, n=3. For better recognition and distinction the z-value of the z-stacks was increased five times. The yellow line indicates the border
between the outer plexiform layer (OPL) and the ONL. DP: deep plexus, IP: intermediate plexus, PP: primary plexus. f Relative gene expression of
hypoxic target genes in coneΔVhlHif1a mice (green) and ctrl mice (R91W;Nrl-/-;Vhlf/f; Hif1af/f, black) at 4we, 8we and 12we as indicated. Abbreviations as in
Figs. 1 and 3. Expression levels were normalized to Actb and compared to 4-week-old ctrl mice, which were set to 1. Shown are means ± SD. n≥3 per
time point. Scale bar 50 μm
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This suggests that the long-term activation of HIF1 may
reduce cell survival by an intrinsic mechanism. During
hypoxia, HIF1 regulates mitochondrial respiration and
thus metabolic adaptation towards glycolysis [72] leading
to reduced energy (ATP) levels and potentially starva-
tion. It has been shown that starvation of cones may
lead to cone cell death [73]. Furthermore, it has been
suggested that cones might be more sensitive to reduced
oxygen and nutrient levels compared to rods, for reasons
not fully understood [74, 75]. This could possibly explain
the progressive degeneration and the accelerated pheno-
type in coneΔVhl compared to rodΔVhl mice.
It might also be possible, however, that photoreceptor
degeneration is secondary to the early pathological vas-
cular defects. Inactivation of Vhl in the retinal periphery
during development leads to vessel growth into the ONL
and severe retinal degeneration [52, 76]. Whereas the
retinal periphery was strongly degenerated at 10 weeks
of age, photoreceptor loss in the normal vascularized
central retina was less pronounced [52]. We observed
microglia activation and impaired function of the blood-
retina-barrier in coneΔVhl mice, as shown by IBA1 and
ALB staining, respectively (Fig. 4h-k). It seems likely that
retinal hemorrhages exacerbate cone photoreceptor de-
generation in our model, as suggested for other models
[77, 78]. Photoreceptor degeneration was also observed
in very low density lipoprotein receptor knockout mice
(Vldlr-/-; [79]) where early retinal neovascularization
causes vessels to extend from the deep plexus into the
subretinal space [80, 81]. Interestingly, it has been sug-
gested that the Vldlr-/- phenotype is linked to HIF1A. Joyal
and colleagues proposed that starved Vldlr-/- photorecep-
tors have reduced amounts of the Krebs cycle metabolite
α-ketoglutarate, which decreases PHD activity and thus
promotes stabilization of HIF1A. Consequently,Vegf is se-
creted, leading to RAP-like neovascularization [82]. We
hypothesize that the combination of early vascular defects
and the activation of a chronic hypoxia-like response,
which affects expression of genes involved in cellular me-
tabolism and retinal stress, leads to the progressive cone
degeneration observed in coneΔVhl mice.
Our findings identify HIF1 in cones as the factor
causing cone degeneration, pathological neovasculari-
zation and loss of function. Similarly, chronic activa-
tion of the hypoxic response in rods resulted in an
HIF1- and age-dependent retinal degeneration (Bar-
ben et al., submitted). Whereas this provides strong
evidence that activation of HIF1 in rod and cone
photoreceptors leads to retinal degeneration, the acti-
vation of HIF2 but not of HIF1 is responsible for
metabolic stress in RPE upon RPE-specific Vhl inacti-
vation [75]. Thus, our data and data published by
others suggest cell type-specific roles for HIF1A and
HIF2A in retinal pathology.
Conclusions
Our data demonstrate that a chronic hypoxic response in
cone photoreceptors induces HIF1A-mediated patho-
logical vessel growth and cone degeneration. Evidence
shows that HIF1A can be safely inactivated in cones (see
above), rods ([38], Barben et al., submitted) and RPE [75]
suggesting that targeting HIF transcription factors in pho-
toreceptors and RPE may provide a potential therapeutic
approach to rescue hypoxia-mediated retinal degeneration
in patients and an alternative to anti-VEGF agents.
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